Skip to content

The effectiveness of a mindfulness-based stress reduction (MBSR) programme for parents of children with attention deficit hyperactivity disorder (ADHD): a pilot randomized controlled trial.

Tsui Yuk Law, Daniel Bressington, Jiayin Ruan, Wai Kit Wong, Yim Wah Mak

BMC psychology April 24, 2025 DOI: 10.1186/s40359-025-02747-4 via PubMed

Summary

AI-generated from the abstract

A pilot randomized controlled trial tested mindfulness-based stress reduction (MBSR) for Chinese parents of children aged 3–12 with ADHD during the COVID-19 pandemic. Thirty-six parents were randomly assigned to MBSR or usual care; all completed the program. Self-perceived stress in the MBSR group dropped from 29.44 before intervention to 25.50 immediately after and 24.72 one month later. Parental stress scale scores fell from 74.50 to 68.94 and then to 67.50. The MBSR group showed significantly greater stress reduction than usual care. 66% of participants reported satisfaction, suggesting MBSR is feasible and effective for reducing parental stress in this population.

Study at a glance

Characteristics Pilot randomized controlled trial Pilot study Peer reviewed
Sample size 36
Population Chinese parents of children aged 3-12 with ADHD
Intervention Mindfulness-based stress reduction (MBSR) programme
Duration 8-week intervention, one-month follow-up
Keywords ADHD Mindfulness-based stress reduction Parental stress
Citations 4
Registration NCT06210113
Key finding Mindfulness-based stress reduction significantly reduced self-perceived stress and parental stress in Chinese parents of children with ADHD compared to usual care, with benefits sustained at one month.

Abstract

Parents of children with attention deficit hyperactivity disorder (ADHD) often experience high levels of parental stress. This has exacerbated during the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to examine the effectiveness of mindfulness-based stress reduction (MBSR) programme in the Chinese population, which is feasible among Chinese parents during the COVID-19 pandemic period in reducing the parental stress of parents compared with the usual care group. This study was designed as a pilot randomized controlled trial with single-blind repeated measures. Parents of children aged 3-12 years with a diagnosis of ADHD were recruited from the parent resource center (PRC) of a local nongovernmental organization between June and August 2022. The participants were randomly assigned to the MBSR intervention group (n = 18) or usual care group (n = 18). With respect to the feasibility of the study, all 36 participants who were randomized fully completed the MBSR programme and assessments, resulting in a 100% attendance rate. 66% of the participants in the intervention group reported satisfaction with the intervention, which was helpful in reducing stress. They were willing to stay on this mindfulness-based programme in the future. The results of the repeated-measures ANOVA revealed a significant difference in self-perceived stress reduction between the groups (p < 0.001, ES = 0.192). The of within-group results revealed that the mean score of the intervention group decreased from 29.44 before the intervention to 25.50 (p < 0.001) immediately after intervention, and further decreased to 24.72 (p < 0.05) at one month after the intervention. By using the parental stress scale, the interaction effects also revealed significant differences between groups (p < 0.001, ES = 0.599). The stress level of the intervention group decreased from 74.50 before intervention, to 68.94 (p < 0.001) immediately after intervention, and further decreased to 67.50 (p < 0.05) at one month after intervention. These reports revealed statistically significant improvements in stress reduction and parental stress reduction in the intervention group. The pilot study revealed that MBSR is feasible and acceptable for parents of children with ADHD in Chinese culture. The findings also suggested that the MBSR programme was effective in reducing parental stress and enhancing mental well-being. This study was registered in the National Library of Medicine, National Center for Biotechnology Information Clinical Trials Registry as Version 1, and the trial registration data are available as NCT06210113, 28/2/2024.

Comments

No comments yet.

Log in to comment